You are here: Home » News-CM » Companies » News
Business Standard

Shilpa Medicare receives USFDA warning letter for its Jadcherla facility, Telangana

Capital Market 

Shilpa Medicare has received a warning letter on 9 October 2020 at 10:06 PM (India Time) through email from the USFDA for its Jadcherla facility, Telangana.

The company will be engaging with the agency and are fully committed in resolving this issue at the earliest.

The Company is also committed in maintaining the highest standards of compliances and quality manufacturing across all its facilities.

The Company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from operations of this facility.

Shilpa Medicare currently has three manufacturing facilities approved by USFDA - One formulation facility and two API facilities. None of these facilities except Jadcherla has any outstanding issues with the USFDA at this point of time.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, October 12 2020. 12:55 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU